Strategic partnership Aphea.Bio has active high-profile partnership activity, including a strategic research collaboration and formal partnership with Bayer to co-develop bioinsecticides. This signals openness to tiered collaborations and potential channel or co-development opportunities for our own products.

Large funding With substantial funding rounds and a EUR70M Series C, Aphea.Bio is positioned for scaling and may seek partners for commercialization, manufacturing scale-up, and international market access to accelerate adoption of biocontrol and biostimulant solutions.

Sustainability focus As a B Corp member dedicated to reducing ecological footprint and promoting biodiversity, Aphea.Bio prioritizes sustainable agriculture solutions. This alignment offers opportunities to position products to sustainability-driven customers and grant-funded programs.

Technology leverage APEXbio R&D platform and expertise in microorganisms suggest a fit for collaborative R&D, screening, and tailored biocontrol/biostimulant development, including joint product pipelines and custom solutions for major crops or sap-sucking pest management.

Growth potential Recent funding, strategic partnerships, and a scalable business model indicate readiness for rapid expansion. This creates sales opportunities in regions or segments targeting farmer networks, distributors, and academic-industrial partnerships seeking proven biobased alternatives.